HDAC8 is activated by SREBP1, an insulin-responsive transcription factor, which activates the transcription of lipogenic genes, and HDAC8 deficiency in obesity-associated mouse models of NASH and HCC ameliorated insulin resistance, reducing triglyceride levels and tumour growth. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatohepatitis.